Table 1.
Clinical characteristics of patients with neuroendocrine tumors
| |
Metastases or recurrences |
|
|
|---|---|---|---|
| + (Group A, n = 7) | - (Group B, n = 38) | p value | |
| Gender |
|
|
0.39 |
| Male |
4 |
28 |
|
| Female |
3 |
10 |
|
| Mean age |
58.4 (41—75) |
61.9 (38—86) |
0.50 |
| Location |
|
|
1 |
| Stomach |
0 |
4 |
|
| Duodenum |
2 (20.0%) |
8 |
|
| Small intestine |
0 |
1 |
|
| Colon |
0 |
1 |
|
| Rectum |
5 (17.2%) |
24 |
|
| Tumor invasion |
|
|
0.16 |
| M |
0 |
1 |
|
| SM |
4 |
28 |
|
| MP |
2 |
3 |
|
| SS |
1 |
1 |
|
| Unknown |
0 |
5 |
|
| Resection methods |
|
|
0.34 |
| Biopsy |
0 |
5 |
|
| Endoscopic resection |
2 |
19 |
|
| Surgical resection |
5 |
14 |
|
| Mean tumor size (mm) | 12.9 (3.5—27) | 7.4 (1.5—15) | 0.26 |
Group A: the cases with metastases or recurrences.
Group B: the cases without metastases or recurrences.
Statistically significant difference (<0.05) by Fisher’s exact test or Welch two sample t-test.